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Orphan nuclear receptor ERRa (NR3B1) is rec-
ognized as a key regulator of mitochondrial bio-
genesis, but it is not known whether ERRa and
other ERR isoforms play a broader role in
cardiac energetics and function. We used
genome-wide location analysis and expression
profiling to appraise the role of ERRa and g
(NR3B3) in the adult heart. Our data indicate
that the two receptors, acting as nonobligatory
heterodimers, target a common set of pro-
moters involved in the uptake of energy sub-
strates, production and transport of ATP across
the mitochondrial membranes, and intracellular
fuel sensing, as well as Ca2+ handling and con-
tractile work. Motif-finding algorithms assisted
by functional studies indicated that ERR target
promoters are enriched for NRF-1, CREB, and
STAT3 binding sites. Our study thus reveals
that the ERRs orchestrate a comprehensive
cardiac transcriptional program and further
suggests that modulation of ERR activities
could be used to manage cardiomyopathies.
INTRODUCTION
To function as an efficient and reliable pump and remain
healthy, the heart must relentlessly produce enough ATP
to sustain intracellular Ca2+ homeostasis for contraction.
The heart must be able to switch between carbohydrates
and fatty acids (FAs) as sources of energy in response to
the physiological status of the organism and to gauge
the cellular energy content of cardiomyocytes (Taegt-
meyer et al., 2004). This metabolic plasticity is mediated
by allosteric controls and phosphorylation cascades for
short-term adjustments as well as gene regulatory mech-
anisms that involve coordinated expression changes inCmetabolic pathway genes for enduring alterations. This
regulatory system requires the parallel regulation of a
network of genes encoding proteins implicated in FA
and glucose uptake, delivery of intermediates into the
mitochondria, FA b-oxidation (FAO), and pyruvate oxida-
tion complexes, as well as the shared oxidative pathways
of tricarboxylic acid (TCA), the electron transport complex
(ETC), and oxidative phosphorylation (OXPHOS). Coordi-
nately regulated on the utilization side are proteins in-
volved in mitochondrial/cytoplasmic ADP-ATP exchange,
phosphate transfer, and fuel sensing and ATPases in-
volved in Ca2+ uptake and actomyosin crossbridging.
While several transcription factors are known to play
essential roles in heart development and the control of
energy metabolism (Huss and Kelly, 2004; Olson, 2006;
Scarpulla, 2006), no single factor or set of related factors
have been shown to integrate the regulation of energy
generation and utilization in a comprehensive manner.
The estrogen-related receptors (ERRs) were the first
orphan members of the superfamily of nuclear receptors
to be identified, and the subfamily is now known to contain
three related isoforms, ERRa (NR3B1, Esrra), b (NR3B2,
Esrrb), and g (NR3B3, Esrrg) (Gigue`re, 1999; Gigue`re
et al., 1988). Despite their structural homology with the
estrogen receptors, the ERRs are not activated by estro-
gens or known to be activated by other natural com-
pounds. Instead, the transcriptional activity of the ERRs
is dependent on interactions with coactivators, in particu-
lar PGC-1a and PGC-1b (Huss et al., 2002; Kamei et al.,
2003; Laganie`re et al., 2004; Mootha et al., 2004;
Schreiber et al., 2003). The functional relationship be-
tween the ERRs and PGC-1 coactivators is of significant
interest as these coactivators are known to play essential
roles in mitochondrial biogenesis (reviewed in Lin et al.,
2005). ERRa and PGC-1a are coexpressed in tissues
with high energy demands and are coinduced in a tis-
sue-specific fashion developmentally and in response to
physiological stresses such as fasting, exposure to cold,
and physical exercise (Cartoni et al., 2005; Ichida et al.,
2002; Puigserver et al., 1998; Schreiber et al., 2003;ell Metabolism 5, 345–356, May 2007 ª2007 Elsevier Inc. 345
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pressed in mitochondria-rich tissues with high energy
needs such as the heart, kidneys, and brown adipose
tissue (Hong et al., 1999; Lin et al., 2002). In addition, over-
expression of PGC-1a leads to a global increase in mito-
chondrial number and function and has been shown to
selectively drive a FAO program involving ERRa in cardiac
and skeletal myocytes (Huss et al., 2004; Mootha et al.,
2004; Schreiber et al., 2004; Wende et al., 2005). It was
observed that the promoters of PGC-1a-induced genes
often contain nuclear receptor core half-sites that resem-
ble putative ERR and other orphan nuclear receptor bind-
ing sites (Mootha et al., 2004) and that inhibiting ERRa
activity by using a siRNA or a small inverse agonist in
cultured cells reduces the ability of PGC-1a to induce res-
piration and mitochondrial biogenesis (Mootha et al.,
2004; Schreiber et al., 2004). Taken together, these stud-
ies provide a strong basis for further investigating the
functional roles of ERRa and evaluating the function of
other ERR isoforms in energy metabolism.
Location analysis of transcription factor occupancy by
a combination of chromatin immunoprecipitation (ChIP)
and genomic DNA arrays (ChIP-on-chip) is a powerful
tool that allows the unbiased identification of direct targets
bound by a given factor or sets of factors (reviewed in Blais
and Dynlacht, 2005). In particular, analysis of binding sites
for nuclear receptors has revealed biological pathways
controlled by a given receptor in a specific tissue or under
a particular physiological condition, as well as new fea-
tures of transcriptional control (Carroll et al., 2005, 2006;
Cheng et al., 2006; Laganie`re et al., 2005; Odom et al.,
2004). In this study, we have used a combination of
ChIP-on-chip and expression profiling approaches to
identify the promoters to which ERRa and g bind in the
adult mouse heart and to investigate changes in gene
and protein expression when levels of ERRa are manipu-
lated in vivo and ex vivo. Our results demonstrate that
ERRa and g act as global and physiologically relevant
pleiotropic regulators of heart functions.
RESULTS
ChIP-on-Chip Analysis of ERRa and g Binding
In order to identify genes directly regulated by ERRa and g
in the heart of adult mice in a genome-wide manner, we
used ChIP with antisera developed against ERRa and g
and a custom DNA microarray containing the region
spanning 800 bp upstream and 200 bp downstream of
transcriptional start sites of 18,657 mouse genes. We
identified 195 and 231 (p % 0.01) promoters bound by
ERRa and g, respectively, and a significant overlap be-
tween the targets of the two ERR isoforms was observed
(Figure 1A, top panel; see also Figure S1 and Table S1 in
the Supplemental Data available with this article online).
We used Gene Ontology (GO) (Al-Shahrour et al., 2004)
annotations and NCBI gene descriptions to classify the
ERRa and g target genes into functional categories and
found that, collectively, the two receptors regulate a
wide array of cellular processes and molecular functions346 Cell Metabolism 5, 345–356, May 2007 ª2007 Elsevier Inc.(Figure 1B and Table S1). Consistent with the proposed
role of ERRa in the regulation of mitochondrial functions,
a significant number of target genes encode proteins in-
volved in OXPHOS and the TCA cycle. Indeed, three
previously validated ERRa targets, Acadm, Cycs, and
Atp5b, are included in this group (Mootha et al., 2004;
Schreiber et al., 2004; Sladek et al., 1997; Vega and Kelly,
1997). However, validation of our ChIP-on-chip data as
described below considerably expands the repertoire of
direct mitochondrial ERR targets. Among the identified
mitochondrial targets were components of the TCA cycle
(Fh1, Sdha, Sdhb, and Sdhd), electron-transferring flavo-
proteins (Etfb and Etfdh), numerous constituents of the
OXPHOS machinery (e.g., Atp5g3, Coq7, Cox6c, and
Ndufa8), and genes involved in energy transfer (Ckmt2
and Slc25a4, better known as ANT1) and amino acid me-
tabolism (Got2). The two ERRs were also found to bind to
the Cyp27a1 promoter. CYP27A1 is a mitochondrial-
membrane-bound member of the cytochrome P450
superfamily of enzymes that play an important role in
cholesterol metabolism.
Other target genes directly link the ERRs with the regu-
lation of glucose and FA metabolism. These genes include
the previously validated ERRa target Pdk4 (Araki and
Motojima, 2006; Wende et al., 2005) and also Slc2a12
(Glut12), Hk2 (hexokinase 2), H6pd (glucose-6-phosphate
dehydrogenase), Ldhb (lactate dehydrogenase B), Vldlr
(very low-density lipoprotein receptor), Slc25a29 (CACL,
palmitoylcarnitine transporter), and Fabp3 (H-FABP).
Although not found by ChIP-on-chip due to the design of
the array, both ERRa and g were found to bind to the first
intron of Glut4 by standard ChIP (data not shown). Also
included among the ERR targets were genes specifically
involved in muscle function such as Casq2 (calsequestrin
2), Ldb3 (cypher), and Tcap (telethonin). The ERRs also
bind to the promoter regions of several genes encoding
transcription factors such as the well-characterized tar-
gets Esrra (ERRa) and Gabpa (NRF-2) (Laganie`re et al.,
2004; Mootha et al., 2004) and also Rara (RARa) and
Trp53 (p53). The two ERRs also control genes encoding
coregulatory proteins such as Mycbp (AMY-1); Trrap,
a pCAF-associated factor and regulator of both c-Myc
and p53; Snw1, which encodes SKIIP, a coregulator of
RARa and the vitamin D receptor; and Pias3, an inhibitor
of STAT3.
ERRa and g Target the Same Promoters
and Function as Heterodimers In Vivo
Independent location analyses with antisera to ERRa and
g showed a significant overlap between ERRa and g target
promoters set at the high-confidence arbitrary threshold
of p% 0.01 (Figure 1A, top panel and Table S1). Validation
of a large number of target promoters obtained at this
threshold by standard PCR ChIP showed that ERRa and
g were indeed binding to all of their respective promoters
identified by ChIP-on-chip, indicating that by arbitrarily
defining the threshold at p % 0.01, several targets were
missed for both receptors (Figure 1C and Figure S2).
Despite a similar overlap between ERRa and g target
Cell Metabolism
Control of Heart Functions by ERRa/gFigure 1. Genome-wide Promoter Occupancy of ERRa and g in Cardiac Tissue
(A) Venn diagrams illustrating the overlap in ERRa and g direct targets obtained from ChIP-on-chip analyses in mouse heart at p% 0.01 (top panel)
and p% 0.02 (bottom panel).
(B) Pie charts representing the major cellular functions associated with ERRa and g targets enriched in the adult mouse heart at a cutoff of p% 0.01.
(C) Standard ChIP validation of ERRa and g ChIP-on-chip target genes in mouse heart at a cutoff of p% 0.01. Promoters found to be bound by either
ERRa or g or by both nuclear receptors in the ChIP-on-chip experiments were all found to be occupied (R2-fold enrichment) by both receptors when
tested by standard ChIP assays. The results shown are from one experiment based on three independent immunoprecipitations prepared from a pool
of 20 hearts.
(D) Motif-finding algorithms revealed that the consensus ERR response element (ERRE) was found in 69% and 74% of the ERRa and g target
promoters used in the analysis, respectively.
(E) Activation of target promoters by ERRa and g. Each panel displays a schematic representation of the target promoter sequences cloned upstream
of the luciferase reporter gene and the results of cotransfection assays in COS-1 cells with empty vector, ERRa, ERRg, or combined ERRa and
g expression vectors in the presence (PGC, black bars) or absence (C, white bars) of PGC-1a. To test for ERRE-dependent activation of the Oxt
and Pah promoters by ERRa and g, the identified ERREs were replaced with the CGCTATGCA sequence. Data are shown in relative luciferase units
(RLUs) and are presented as mean ± SEM.promoters when comparison was made using data sets
obtained with p % 0.02 (Figure 1A, bottom panel), many
of the missed ERR targets at p % 0.01 were found using
this less stringent cutoff. These results suggested that
ERRa and g may in fact bind the same repertoire of pro-
moters in the adult heart. We tested this consideration
by performing standard PCR ChIP assays with ERRaand g antisera on individual promoters originally identified
by ChIP-on-chip using the ERRg and a antisera, respec-
tively (Figure 1C and Figure S2). For example, while Hk2,
Plscr2, and Vldlr were identified as ERRa targets in the
ChIP-on-chip experiment, standard ChIP assays showed
these promoters to be equally enriched by the ERRg anti-
serum. Conversely, the Fabp3, Ldb3, and Timm8b/SdhdCell Metabolism 5, 345–356, May 2007 ª2007 Elsevier Inc. 347
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standard ChIP assays also demonstrated their regulatory
regions to be targets for ERRa.
The results of the genome location analysis were further
validated by using a motif-finding algorithm that inspects
the ChIP-on-chip selected sequences and searches for
DNA sequence motifs representing the protein:DNA inter-
action sites (Liu et al., 2002). The consensus sequences
derived from the most frequent motifs found in the
ERRa- or g-bound promoters both correspond to the
ERR response element (ERRE; TCAAGGTCA, Figure 1D)
(Sladek et al., 1997), indicating that both receptor isoforms
recognize the same target sequence. We next examined
whether target promoters identified by ChIP-on-chip
experiments were indeed responsive to ERRa and g. We
tested six promoters containing one or more consensus
ERREs, including the previously validated ERRa target
Cycs, by measuring their response in a cotransfection as-
say to ERRa, ERRg, or a combination of both receptors in
the presence or absence of the coactivator PGC-1a
(Figure 1E). While promoters displayed individual varia-
tions in the potency of the response to the receptors
(from 1.5- to 50-fold), all promoters responded to the pres-
ence of ERRa and g. The basal transcriptional activity of
both ERR isoforms is generally low in the absence of
external stimuli but in most instances can be forcefully
increased by the introduction of PGC-1a. As expected,
ERRa and g were found to directly bind to the indicated
ERREs (Figure 1E and Figure S3), while mutations of
the ERREs in the Oxt and Pah promoters significantly re-
duced the transcriptional activity of ERRa and g on these
promoters (Figure 1E, lower panels).
ERRa is known to bind to the ERRE as both a dimer and
a monomer (Barry et al., 2006; Laganie`re et al., 2004).
Analysis and validation of the ChIP-on-chip experiments
showed that ERRa and g share the same target promoters
and recognize the same ERRE binding motif. Thus, one
possible interpretation of these data is that the two ERR
isoforms could form functional heterodimers. We first
tested whether ERRa and g could bind an ERRE as heter-
odimers in vitro. As shown in Figure 2A (left panel), coex-
pression of the two receptor isoforms leads to the forma-
tion of an intermediate band in the gel shift assay,
indicating the presence of an ERRa/g heterodimer in the
binding reaction. Furthermore, all three ERR complexes
(ERRa/a, ERRa/g, and ERRg/g) could be supershifted in
the presence of a PGC-1a fragment containing the LxxLL
interaction motifs, demonstrating that both homodimer
and heterodimer complexes recognize their coactivator
‘‘ligand’’ (Figure 2A, right panel).
We next determined whether ERRa and g interact
in vivo. We first subjected lysates prepared from wild-
type hearts to immunoprecipitation with anti-ERRa or
anti-ERRg antisera followed by western blotting with
anti-ERRa or anti-ERRg antisera. As shown in Figure 2B,
ERRa could be detected in the extract immunoprecipi-
tated with the ERRg antiserum (top panel), while ERRg
could be detected in the extract immunoprecipitated
with the ERRa antiserum (bottom panel). As a control, we348 Cell Metabolism 5, 345–356, May 2007 ª2007 Elsevier Inc.performed the same experiment using lysates prepared
from hearts obtained from ERRa null mice. As expected,
only ERRg could be detected, and only when the proteins
were immunoprecipitated using the ERRg antiserum. To
further demonstrate that ERRa and g form heterodimeric
complexes on chromatin, we performed serial ChIP exper-
iments. The Pdk4, Plscr2, and Timm8b/Sdhd promoters,
but not the control region, were enriched after serial ChIP
Figure 2. ERRa and g Form Heterodimers, but ERRa Is Not
Essential for ERRg Promoter Occupancy in the Mouse Heart
(A) ERRa and g form functional heterodimers in vitro. ERRa,DN-ERRg,
or both proteins together were incubated with an ERRE probe with
(right panel) or without (left panel) a GST-PGC-1a fusion protein. H
and S indicate the heterodimeric ERRa/g complex and the super-
shifted ERR/PGC-1a complexes, respectively.
(B) ERRa and g interact in vivo. Lysates from wild-type (WT) and ERRa
null hearts were subjected to immunoprecipitation with either anti-
ERRa or anti-ERRg antibodies and then subjected to immunoblot
analysis with either anti-ERRa (top lane) or anti-ERRg (bottom lane).
(C) Re-ChIP experiments performed on the Pdk4, Plscr2, and Timm8b/
Sdhd promoters as well as on a control region using either anti-ERRa
or anti-ERRg antibodies in a serial manner. The results shown are from
one experiment based on two independent immunoprecipitations pre-
pared from a pool of 20 hearts; error bars represent standard deviation.
(D) ERRg promoter occupancy in ERRa null hearts. ERRg was found
to be enriched at ERR target promoters identified by ChIP-on-chip
experiments despite the absence of ERRa as determined by standard
ChIP assays. The results shown are from one experiment based on
three independent immunoprecipitations prepared from a pool of 20
hearts.
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together at the same genomic locations. It is important to
note that the primers specific for the target promoters
amplify genomic regions containing a single identified
ERRE (Figure 2C). We next tested whether the presence
of ERRa was required for ERRg to recognize ERR target
genes. We thus performed standard ChIP assays using
the ERRg antiserum and chromatin isolated from wild-
type and ERRa null hearts on 14 different target promoters
(Figure 2D). The levels of enrichment of ERRg at these
promoters were either comparable or slighter higher
when tested with chromatin isolated from ERRa null
hearts, indicating that ERRg can bind DNA efficiently in
the absence of ERRa.
CREB and STAT3 Partner with the ERRs to Activate
Metabolic Target Genes
To identify cooperating factors that could modulate ERRa
and g function, we first searched ERR target promoters
for known transcription factor binding sites. The set of
TRANSFAC position-weight matrices whose sites are en-
riched within the ERR target promoters obtained from our
ChIP-on-chip assays are shown in Table 1. In agreement
with the results obtained with the motif-finding algorithm
(Figure 1D), the hits for ERR (matrix M00511) are the
most enriched. Analyzing the ERRE-containing regions
and the non-ERRE-containing regions separately, we
found that STAT1 (matrix M00224), STAT3 (matrix
M00225), and NRF-1 (matrix M00652) are highly enriched
in the ERRE-containing promoters, but not in the non-
ERRE-containing regions. On the other hand, binding sites
for CREB appear to be enriched in both ERRE- and non-
ERRE-containing promoters.
We next examined whether the presence of CREB and
STAT binding sites has functional significance for ERRa
function. The Cycs promoter is a validated ERRa target
that also contains a CREB binding site (Schreiber et al.,
2004; Zhang et al., 2005). The Cycs promoter was thus
fused to the luciferase reporter gene, and the construct
was cotransfected together with expression vectors for
ERRa and CREB in the presence of the ERRa coactivator
‘‘ligand’’ PGC-1a. As shown in Figure 3A, ERRa and CREB
display small but significant transcriptional activities on
the Cycs promoter. However, when added together,
a much more potent activation of the Cycs promoter
Table 1. Enrichment p Values of Top Ranking Factors
Predicted in ERRa/g Target Promoters
Module Factor All ERRE+ ERRE
M00511 ERRa 3 3 1018 NA NA
M00225 STAT3 6 3 103 3 3 104 0.54
M00652 NRF-1 6 3 102 6 3 105 0.88
M00224 STAT1 6 3 103 1 3 104 0.67
M00039 CREB 2 3 106 6 3 104 9 3 103
p values in italics indicate significant enrichment of associated
transcription factor binding sites. NA = not applicable.Cwas observed. Interestingly, introduction of a dominant-
negative form of CREB (A-CREB) abolished the transcrip-
tional activity of ERRa on the Cycs promoter, indicating
that the action of CREB is required for ERRa function on
this particular promoter. Similar results were obtained
when using a Pah reporter construct also containing
a CREB binding site (Figure 3A). As a control, we used
the Pias3 regulatory region lacking a CREB binding motif
to ensure that the effect seen by CREB and A-CREB on
ERRa activity on the Cycs and Pah promoters is depen-
dent on the presence of a functional CREB binding site
(Figure S4). As predicted, CREB and A-CREB had no ef-
fect on the ERRa transcriptional response with the Pias3
regulatory region. We next investigated the action of
ERRa with STAT1 or STAT3 on the Pias3 regulatory re-
gion. Pias3 is an interesting ERR target, as this factor,
a known inhibitor of STAT3 function, could be involved in
a regulatory feedback loop. Figure 3B shows that ERRa
is a potent activator of Pias3. On the other hand, constitu-
tively active forms of both STAT1 (STAT1c) and STAT3
(STAT3c) failed to activate transcription from the Pias3
regulatory region. However, cotransfection of ERRa and
STAT3c resulted in a synergistic action of the two factors,
while STAT1c had no effect.
Figure 3. Functional Interaction between ERRa, CREB, and
STAT3 on ERR Target Promoters
(A) CREB is required for the PGC-1a-induced transcriptional activity of
ERRa on the Cycs and Pah promoters. Dominant-negative CREB
(A-CREB) abrogated the activation observed with ERRa. Data in (A)
and (B) are shown in relative luciferase units (RLUs) and are presented
as mean ± SEM.
(B) STAT3 specifically synergizes the activity of ERRa on the Pias3
regulatory region. A Pias3 luciferase reporter construct was co-
transfected with empty vector or an ERRa expression vector in the
presence of constitutively active STAT3 (STAT3c) or STAT1 (STAT1c).ell Metabolism 5, 345–356, May 2007 ª2007 Elsevier Inc. 349
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ERRa Null Hearts
(A) Pie charts representing the major cellular
functions of upregulated and downregulated
genes in mouse hearts lacking ERRa at a cut-
off of p % 0.001 and relative fold change
(log2) ± 0.5.
(B) Schematic representation of a set of differ-
entially regulated genes involved in selected
biological processes expressed as relative
fold change (log2).
(C) Hearts lacking ERRa have more active ace-
tyl-CoA carboxylase b. Protein lysates from
wild-type and ERRa null mouse hearts were
probed with antibodies against phospho-
ACC, ACC, phospho-AMPKa, AMPKa, and
AMPKb1 and 2. Immunoblotting with anti-a-
tubulin served as a control for equal loading.
(D) Standard ChIP validation of ERRa and g
binding to targets not identified in the original
ChIP-on-chip experiment that are involved in
the fuel-sensing pathway. The results shown
are from one experiment based on three inde-
pendent immunoprecipitations prepared from
a pool of 20 hearts.
(E) Real-time qRT-PCR performed on RNA iso-
lated from adult mouse hearts used in the mi-
croarray analysis. Relative fold (log2) expres-
sion levels were normalized to b-actin levels
and are presented as mean ± SEM.
(F) Additive effect of the loss of ERRa and g
regulation on target gene expression. Relative
expression of ERRa and g target genes not sig-
nificantly altered in ERRa null hearts is affected
by the simultaneous loss of ERRg expression
and inhibition of ERRa activity. Quantitative
real-time PCR was performed on RNA isolated
from mouse HL-1 atrial myocytes stably ex-
pressing either GFP or a siERRg-encoding
adenovirus following treatment with vehicle
(0.1% DMSO) or the ERRa inverse agonist
XCT790 (1 mM) for 24 hr. Results of two inde-
pendent experiments performed in duplicate
are shown as the mean ± SEM of relative fold
expression levels normalized to Arbp levels.Expression Profiling and Disruption
of the Fuel-Sensing Pathway in ERRa Null Mice
To further explore the role of ERRa in the heart, we next
examined the effects of loss of ERRa function on global
gene expression in the heart. The results first revealed
that more genes are upregulated than downregulated
(225 versus 180) in the ERRa null heart (Figure 4A). GO
analysis of the microarray data set shows that genes in-
volved in heart and muscle development, muscle contrac-
tion, lipid metabolism, OXPHOS, protein metabolism, and
transcription are well represented (Figure 4A). Changes in
the expression of transcription factors and coregulators
having important roles in myocardial development and
function such as Irx4, Egr1, Jarid2, and Id2 are shown
(Figure 4B). Interestingly, ERRa and g bind to a regulatory350 Cell Metabolism 5, 345–356, May 2007 ª2007 Elsevier Inc.region located 4.7 kb upstream of the Jarid2 tran-
scription start site (TSS), suggesting that Jarid2 is also
a direct ERR target (data not shown). In addition, the ex-
pression levels of several genes encoding proteins in-
volved in Ca2+ handling and muscle contraction (e.g.,
Acta1, Hrc, Ryr2, Tcap, Myl1, Myl4, Myl7, Myl9, Pdlim3,
Pdlim5, and Sln) were altered. Moreover, genes involved
in glucose (Glut1 andHk2) and FA (Vldlr,Cpt2, andHadha)
metabolism were found to be deregulated in ERRa null
hearts. As expected, several OXPHOS genes (e.g., Coq7
and Ndufs4) were downregulated. On the other hand,
changes in the expression levels of the AMPKb subunits
(Prkab1 and Prkab2) as well as malonyl-CoA decarboxy-
lase (Mlycd) revealed an important role for ERRa in fuel
sensing.
Cell Metabolism
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coincided with a decrease in AMPKb1 and AMPKb2 pro-
tein levels (Figure 4C). Although the expression levels of
the AMPKa subunits were not significantly altered in the
ERRa null hearts validated by qRT-PCR validation (data
not shown), the AMPKa1 and AMPKa2 protein levels
were found to be decreased in the ERRa null mice
(Figure 4C). In addition, we also examined whether
AMPK activity would be affected in the ERRa null heart.
As can be observed in Figure 4C, phosphorylation of the
catalytic a subunit of AMPK at Thr172 is reduced. Accord-
ingly, we also found decreased phosphorylation of ACC2,
the prime target of AMPK in the control of FAO (reviewed
in Kahn et al., 2005). ACC2 catalyzes the conversion of
acetyl-CoA to malonyl-CoA, which inhibits CPT1, the
rate-limiting step in FA metabolism (Abu-Elheiga et al.,
2000). Mice lacking ACC2 exhibit increased rates of FAO
in both the heart and skeletal muscle, where ACC2 is
found to be primarily expressed (Abu-Elheiga et al.,
2001). Interestingly, ERRa and g were found to be en-
riched by standard ChIP at the first intron of Cpt1a (data
not shown). Taken together, the downregulation of Mlycd
(MCD) expression and potential increased ACC2 activity
(as predicted by a reduction in phosphorylation status) in
the ERRa null heart suggests an important role for ERRa
in the maintenance of the cellular energy-sensing appara-
tus. Finally, because some promoters were absent from
our genomic DNA array, we examined whether ERRa
and g could directly target additional genes that play
a role in the energy-sensing apparatus. Of particular inter-
est, we found that Lkb1 (Stk11), which encodes the phys-
iologically relevant AMPK kinase (AMPKK), and Mlycd
regulatory regions could be enriched with both ERRa
and g antisera (Figure 4D).
Overall, 14 ERRa and g target genes identified by ChIP-
on-chip were found to be altered in the ERRa null hearts.
The differential expression of these genes, including
Hk2, Vldlr, Coq7, Eno1, Tcap, and Trp53, had no relation
to whether they were found to be targets of ERRa or
ERRg or were common to both at p% 0.01. In the cluster
associated with transcription (Figure 4B), the ERR core-
pressor Nrip1 (RIP-140) was downregulated while expres-
sion of the coactivator Ppargc1a (PGC-1a) was elevated,
suggesting a mechanism to compensate for the absence
of ERRa. This suggestion was strengthened by the obser-
vation that, in addition to higher levels of PGC-1a, the
relative expression of ERRg and PPARgwas also elevated
in the hearts of ERRa null mice (Figure 4E). In agreement
with these observations, ERRa null hearts exhibit only
modest differences in the expression of critical enzymes
involved in mitochondrial ATP synthesis (Figure S5). To
further test this hypothesis, HL-1 cardiomyocytes stably
expressing GFP or GFP and a siERRg-encoding adenovi-
rus were treated with a selective ERRa inverse agonist,
and qRT-PCR was performed on ERRa and g target genes
not significantly altered in the ERRa null hearts (Figure 4F).
The ERRa inverse agonist XCT790 alone had little effect
on the expression of target genes, similar to the results
observed in hearts lacking ERRa. A more significantreduction in transcript levels was seen in cardiomyocytes
expressing a siRNA against ERRg, with an added de-
crease in expression when treated with XCT790.
We next sought to further explore the potential for ERRa
and g to regulate cardiac contractile and Ca2+ handling
proteins by introducing exogenous ERRa and g in cardiac
myocytes. To this end, we used adenovirus to efficiently
express ERRa or g in rat neonatal cardiac myocytes,
a model used in previous studies to demonstrate activa-
tion of FA uptake and mitochondrial oxidation genes by
ERRa (Huss et al., 2004). Analysis of structural and con-
tractile proteins revealed that ERRa and g robustly acti-
vated transcripts encoding contractile protein isoforms
specifically expressed in adult ventricles, whereas they
had differential effects on isoforms specific to skeletal
myocytes or to atria (Figure 5A). In addition, immunofluo-
rescence detection of a-tubulin, a-actinin, and cardiac
troponin I (TnI) showed that exogenous expression of
ERRa increased cardiac myocyte cytoskeletal and myofi-
bril protein density and organization (Figure 5B). As pre-
dicted by microarray analyses, ERRa and g activated
two genes involved in sarcoplasmic reticulum (SR) Ca2+
handling, SR Ca2+-ATPase (Atp2a2) and its regulatory
partner phospholamban (Pln) (Figure 5A). Furthermore,
standard ChIP analysis of the genes involved in contrac-
tion and Ca2+ handling identified ERRa and g regulatory
binding sites in the proximity of the Myh6, Myh7, Actc1,
Atp2a2, and Pln genes not identified by ChIP-on-chip
studies (Figure 5C). Collectively, these results support
the overlapping regulatory functions of ERRa and g in
cardiac genes engaged in energy synthesis and utilization.
DISCUSSION
The heart is a specialized organ that must relentlessly
produce enough ATP from glucose and FA oxidation to
sustain intracellular Ca2+ homeostasis and contraction.
To maintain its essential function, the heart must regulate
a cascade of biological processes including (1) the uptake
and cytoplasmic processing of energy substrates; (2) the
production of ATP via glucose and FA oxidation, the
TCA cycle, and OXPHOS; (3) the transport of ATP across
the mitochondrial membranes and generation of the phos-
phocreatine pool by creatine kinase; (4) the sensing of
cellular energy charge through the LKB1/AMPK/ACC2/
MCD pathway; and (5) Ca2+ handling and contractile
work. In this study, the combined use of genome-wide lo-
cation and differential gene expression analyses showed
that the orphan nuclear receptors ERRa and g control all
aspects of this integrated process by regulating the
expression of genes involved at each step (Figure 6).
Our data show that ERRa and g target a common set of
promoters, can exist in a heterodimer form in the heart,
and convey transcriptional activation by PGC-1a. These
results therefore support a model in which ERR isoforms
act in concert to regulate a broad genetic program essen-
tial for proper heart function. It is highly likely that ERRb,
the third member of the ERR subfamily expressed in the
heart (Bookout et al., 2006; Gigue`re et al., 1988), alsoCell Metabolism 5, 345–356, May 2007 ª2007 Elsevier Inc. 351
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Control of Heart Functions by ERRa/gFigure 5. ERRa and g Regulation of Genes Encoding Contractile and Ca2+ Handling Proteins Involved in Excitation-Contraction
Coupling in Cardiac Myocytes
(A) Quantitative real-time PCR was performed on RNA isolated from rat neonatal ventricular myocytes expressing GFP, ERRa, or ERRg via adenoviral
infection. Primers were specific for a-myosin heavy chain (Myh6), b-myosin heavy chain (Myh7), cardiac troponin I (Tnni3), a-cardiac actin (Actc1),
Ca2+-ATPase (Atp2a2), and phospholamban (Pln). Data are reported as mean ± SEM arbitrary units internally normalized to Arbp expression and
relative to GFP (=1.0).
(B) Fluorescence microscopy analysis of Ad-GFP- or Ad-ERRa-infected rat neonatal cardiac myocytes. Visualization of GFP, which is expressed from
a separate expression cassette in the adenovirus construct, reveals evidence of morphology changes induced by ERRa expression. ERRa increases
cardiac myocyte cytoskeletal and myofibril protein density and organization as evidenced by immunofluorescence detection of a-tubulin, a-actinin,
and cardiac troponin I (TnI).
(C) Standard ChIP quantitative PCR analysis of genes involved in contraction and Ca2+ handling. ERRa and gwere found to be occupied at regulatory
regions within the Myh6, Myh7, Actc1, Atp2a2, and Pln genes in mouse hearts. The results shown are from one experiment based on three indepen-
dent immunoprecipitations prepared from a pool of 20 hearts; error bars represent standard deviation.participates in this gene regulatory network. It is also prob-
able that the distinct homodimeric and heterodimeric ERR
complexes, whose relative abundance is dictated by their
levels of expression in a particular tissue, may display
differential and cell-specific transcriptional activity. How-
ever, the observation that the ERRa null mouse is viable
and fertile and displays no vital physiological abnormali-
ties in the resting state (Luo et al., 2003) provides further
evidence that the other two ERR isoforms can compen-
sate for its absence under favorable physiological con-
ditions. Indeed, the presence of ERRa is not absolutely352 Cell Metabolism 5, 345–356, May 2007 ª2007 Elsevier Increquired for ERRg binding to ERR target promoters (Fig-
ure 2D). Of particular interest, in the ERRa null heart, the
corepressor Nrip1 (RIP-140) is downregulated while
Ppargc1a (PGC-1a) is upregulated at a time when the ex-
pression of Esrrg (ERRg) is also elevated, suggesting the
establishment of a compensatory transcriptional control
mechanism in the absence of ERRa. The compensatory
mechanism is particularly evident in the HL-1 cardiomyo-
cytes, where ERRgwas shown to play an important role in
maintaining the expression of ERRa target genes. Genetic
redundancy has been documented for other members of.
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Control of Heart Functions by ERRa/gFigure 6. Comprehensive Orchestration of Cardiac Functions by ERRa and g
Schematic representation of biological pathways regulated by ERRa and g in the adult mouse heart. Substrate uptake, transcription, energy produc-
tion (TCA cycle, FAO, and OXPHOS), contractile work, and fuel sensing are represented as gray boxes. A partial list of ERRa and g direct target genes
are shown in red, while genes and proteins with altered levels in expression or activity in hearts lacking ERRa are labeled in blue and green, respec-
tively. Important components of pathways shown for clarity but not regulated by the ERRs in this study are displayed in black. Genes identified by their
official symbols are shown in italics; genes and proteins identified by their common names are shown in uppercase letters.the nuclear receptor superfamily, most notably for the
three RAR isoforms (Mark et al., 2006). However, this
study demonstrates that closely related nuclear receptors
target the same gene networks on a genome-wide scale
and can regulate common biological processes in a tissue
where they are coexpressed.
Our results not only validate the role of ERRa in FAO and
OXPHOS but also implicate ERRg in this process and con-
siderably expand the repertoire of ERR target genes and
associated functions in cardiac energetics. We show
that the global control of heart function by ERRa and g
also involves the direct regulation of transcriptional regu-
lators (e.g., Esrra, Gabpa, Rara, Trp53, Crsp3, Mycbp,
Pias3, and Snw1). The identification of a large number of
ERR target promoters provided the opportunity to investi-
gate whether the ERRs cooperate with other transcription
factors in the heart to regulate gene networks controlling
energy metabolism. In particular, we found that STAT3,
STAT1, and NRF-1 binding motifs were significantly
enriched in promoters containing a consensus ERRE. On
the other hand, the CREB binding motif was enriched in
both ERRE-containing and non-ERRE-containing regions.
NRF-1 is a factor that plays an important role in mito-
chondrial biogenesis and energy production (Scarpulla,
2006). It has been suggested that NRF-1 acts downstream
of the initial PGC-1a-induced expression of ERRa inCemouse myoblasts in culture (Mootha et al., 2004). Our
data argue that NRF-1, as a late mediator of the mitochon-
drial transcriptional program induced by PGC-1a, targets
a set of promoters first bound by the ERRs to ensure
a lasting response to the initiating physiological stimulus.
Significantly, cotransfection of STAT3 or CREB with
ERRa showed a cooperative activation of target pro-
moters. In addition, a dominant-negative form of CREB
decreased the transcriptional activity of ERRa on the
Cycs and Pah promoters, indicating that the action of
CREB was required for ERRa function on these pro-
moters. Interestingly, 53 of the ERR target promoters
identified in this study were recently reported to be en-
riched using a CREB antibody and chromatin obtained
from human HEK293T cells (Zhang et al., 2005). In addi-
tion, STAT3 has been shown to be involved in several
mechanisms required for the protection of the heart from
injury and failure (Hilfiker-Kleiner et al., 2005), suggesting
that the functional interaction between ERRa and STAT3
in the heart is physiologically relevant. The identification
of Pias3 as a direct ERR target further strengthens the
functional link between the ERRs and STAT3 by suggest-
ing the existence of a feedback regulatory loop controlling
the activity of the two factors.
We have demonstrated that the ERRs regulate a broad
genetic program involved in every aspect of heartll Metabolism 5, 345–356, May 2007 ª2007 Elsevier Inc. 353
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Control of Heart Functions by ERRa/gfunction. The biological significance of the ERR target
genes identified in this study is further exemplified by
the knowledge that a large number of these genes have
been linked to specific cardiac phenotypes in mouse
models and/or cardiomyopathies in humans (Table S2).
Our results suggest that ERR agonists could provide
a therapeutic approach to managing diverse cardiomyop-
athies and preventing heart failure. Although the develop-
ment of ERRa agonists has yet to be achieved, our data
show that targeting ERRg could be a rational alternative
(Chao et al., 2006). Finally, if the global role of ERRa and
g in the control of energy metabolism in the heart is con-
served in skeletal muscle, the use of selective ERR mod-
ulators could also be envisaged as a pharmacological
strategy against obesity and the metabolic syndrome.
EXPERIMENTAL PROCEDURES
Animals
Two- to three-month-old male wild-type and ERRa/ mice (Luo et al.,
2003) in a C57BL/6J genetic background were housed in the animal
facility at the McGill University Health Centre and fed standard chow.
ChIP, ChIP-on-Chip, and Quantitative Real-Time PCR
ERRa and g ChIP assays on wild-type and ERRa null adult mouse
hearts for standard ChIP or ChIP-on-chip studies were performed as
described in Supplemental Experimental Procedures using an anti-
hERRa polyclonal antibody raised in our laboratory against the N
terminus (first 74 amino acids) or with a purified specific anti-hERRg
polyclonal antibody raised against the ligand-binding domain (amino
acids 229–458). For ChIP assays, material corresponding to 0.15 g
of initial tissue weight obtained from a pool of at least 20 hearts was
used for each immunoprecipitation. For triplicate genome-wide loca-
tion analyses, material corresponding to 1.5 g of initial heart mass
taken from 44 pooled formaldehyde-crosslinked sonicated hearts
was used for each immunoprecipitation. To assess the enrichment
of ERRa or g at specific promoters, qPCR was performed using mouse
heart standard ChIP samples on a Roche LightCycler instrument with
a program consisting of 15 min at 95C followed by 45 cycles of 15 s at
95C, 30 s at 60C, and 30 s at 72C with a transition temperature of
20C/s. ERR promoter occupancy was quantified using the formula
2ðqPCR cycle of no-antibody control DNAqPCR cycle of enriched DNAÞ:
Enrichment of DNA fragments was normalized against an amplified
control region using the control primers, located approximately 4 kb
upstream of the ERRa transcriptional start site. Table S3 shows the
specific mouse primers designed and used for ChIP qPCR analysis.
Transfection Assays
See Supplemental Experimental Procedures for a description of the
reporter constructs and expression plasmids used for transfections.
Luciferase activity was measured 24 hr posttransfection, and results
are shown in relative luciferase units.
Electromobility Shift Assay, Coimmunoprecipitation,
and Immunoblotting Assays
See Supplemental Experimental Procedures.
Serial ChIP
An initial 10% input sample was kept for subsequent analysis. Follow-
ing immunoprecipitation with either anti-ERRa or anti-ERRg antibody,
enriched crosslinked genomic fragments from mouse heart tissue
were eluted from the immunoprecipitate using two subsequent
elutions with elution buffer (1% SDS, 0.1 M NaHCO3) by incubation
at room temperature for 15 min. For each serial ChIP analysis, 10%354 Cell Metabolism 5, 345–356, May 2007 ª2007 Elsevier Inc.of the immunoprecipitated sample was decrosslinked in elution buffer
by incubation at 65C overnight, and the remaining 90% was reimmu-
noprecipitated with either anti-ERRa or anti-ERRg antibody. Quantifi-
cation of ERRa and g promoter occupancy was performed by calcu-
lating ERR enrichment relative to the initial 10% input sample.
Amplification of ERR-enriched serial ChIP samples using a control
region (4 kb upstream of the Esrra promoter) served to calculate
the overall background of the re-ChIP experiments.
Computational Motif Discovery
De novo motif discovery was performed using MDScan (Liu et al.,
2002) on the extended promoter regions of ERRa/g target genes
(1.5 kb to +0.5 kb from the TSS). The same regions were scanned
for matches to TRANSFAC 7.2 position-weight matrices (PWMs) using
a likelihood ratio approach based on a third-order Markov background
model with locally determined GC content (Blanchette et al., 2006).
Hits with p value below 104 (on either strand) were predicted as puta-
tive binding sites. For each PWM, the total number of sites in the ERR
extended promoters was compared to the number of such sites in the
extended promoters of all genes in the mouse genome, and the site
enrichment was assigned a p value based on a hypergeometric distri-
bution. A similar calculation was performed separately for ERRE-
containing promoters (i.e., those containing at least one predicted
ERR site) and non-ERRE-containing promoters.
Expression Profiling Analysis in Wild-Type versus ERRa
Null Hearts
Triplicate microarray analyses of wild-type and ERRa null hearts were
performed as described in Supplemental Experimental Procedures. A
p value cutoff of%0.001 and a relative fold change (log2) cutoff of ±0.5
were used, and genes were classified by biological function based on
GO annotation (http://fatigo.bioinfo.cipf.es/) and NCBI gene descrip-
tions. Relative fold expression levels of the analyzed genes using spe-
cific primers (Table S4) were normalized to Actb levels in the wild-type
and ERRa null hearts.
Expression Analysis in HL-1 Atrial Myocytes and Rat Neonatal
Ventricular Myocytes
Quantitative real-time PCR was performed as described in Supple-
mental Experimental Procedures on RNA isolated from mouse HL-1
cardiomyocytes stably expressing GFP or a siERRg-encoding adeno-
virus following treatment for 24 hr with either 0.1% DMSO or the selec-
tive ERRa inverse agonist XCT790 (1 mM), which is known to impair
ERRa-mediated transcriptional activity (Willy et al., 2004). Experiments
were performed in duplicate, and expression levels were normalized to
Arbp levels. Similar experiments were performed with RNA isolated
from rat neonatal ventricular myocytes expressing GFP, ERRa, or
ERRg via adenoviral infection. Results were normalized against Arbp
expression and reported relative to GFP (=1.0). Specific primers
used are listed in Table S4.
Immunofluorescence in Primary Ventricular Myocytes
See Supplemental Experimental Procedures.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, five figures, and four tables and can be
found with this article online at http://www.cellmetabolism.org/cgi/
content/full/5/5/345/DC1/.
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